Table 1.
Patient information from TCGA and GSE47994 (n=249 patients)
| Variables | No. Patients (%) | |
|---|---|---|
| Gender | ||
| Female | 249 (100.0%) | |
| Male | 0 (0.0%) | |
| Age (y) | ||
| ≤ 55 | 147 (59.0%) | |
| >55 | 102 (41.0%) | |
| Tumor size | ||
| T1 | 53 (21.3%) | |
| T2 | 168 (67.5%) | |
| T3 | 18 (7.2%) | |
| T4 | 10 (4.0%) | |
| Nodal status | ||
| N0 | 113 (45.4%) | |
| N1 | 74 (29.7%) | |
| N2 | 43 (17.3%) | |
| N3 | 19 (7.6%) | |
| Metastasis | ||
| M0 | 132 (53.0%) | |
| M1 | 102 (41.0%) | |
| Mx | 15 (6.0%) | |
| Pathological grade | ||
| G1 | 35 (14.1%) | |
| G2 | 73 (29.3%) | |
| G3 | 141 (56.6%) | |
| Stage | ||
| I | 50 (20.1%) | |
| II | 79 (31.6%) | |
| III | 68 (27.3%) | |
| IV | 102 (41.0%) | |
| Ki-67 | ||
| < 15% | 43 (17.3%) | |
| ≥ 15% | 206 (82.7%) | |